- |||||||||| nintedanib eye drop (CBT-001) / Cloudbreak Therap
Trial completion date, Trial primary completion date: A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium (clinicaltrials.gov) - Mar 14, 2024
P3, N=600, Recruiting,
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article. Trial primary completion date: Dec 2024 --> Dec 2025 | Trial completion date: Jun 2025 --> Dec 2026
- |||||||||| nintedanib eye drop (CBT-001) / Cloudbreak Therap
Trial completion, Trial completion date, Trial primary completion date: Safety and Efficacy of CBT-001 Ophthalmic Solution in Patients With Pterygium (clinicaltrials.gov) - Sep 5, 2018
P2a, N=75, Completed,
Trial primary completion date: Dec 2024 --> Dec 2025 | Trial completion date: Jun 2025 --> Dec 2026 Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Apr 2018 | Trial primary completion date: Sep 2018 --> Apr 2018
- |||||||||| nintedanib eye drop (CBT-001) / Cloudbreak Therap
Trial primary completion date: Safety and Efficacy of CBT-001 Ophthalmic Solution in Patients With Pterygium (clinicaltrials.gov) - Jul 19, 2018
P2a, N=75, Active, not recruiting,
Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Apr 2018 | Trial primary completion date: Sep 2018 --> Apr 2018 Trial primary completion date: May 2018 --> Sep 2018
- |||||||||| nintedanib eye drop (CBT-001) / Cloudbreak Therap
Enrollment closed, Trial completion date, Trial primary completion date: Safety and Efficacy of CBT-001 Ophthalmic Solution in Patients With Pterygium (clinicaltrials.gov) - Apr 30, 2018
P2a, N=75, Active, not recruiting,
Trial primary completion date: May 2018 --> Sep 2018 Not yet recruiting --> Active, not recruiting | Trial completion date: Feb 2018 --> Sep 2018 | Trial primary completion date: Feb 2018 --> May 2018
|
